Skip to content
Screener

Zevra Therapeutics, Inc. ZVRA Gain Loss On Disposition Of Intangible Assets

Gain Loss On Disposition Of Intangible Assets at other companies

Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$0-100%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$0-100%
TDS
Telephone and Data SystemsTDS
$402.28M+10,772%
ATN International logo
ATN InternationalATNI
$1.55M
KOR
KOREKORE
-$278.75K
MBC
MasterBrandMBC
$0-100%

Other financials

Income statement

See full
Revenue$39.7M+53.3%
Gross profit$38.1M+182%
Operating income$16.8M+124%
Net income$8.8M-88.3%
EPS (diluted)$0.14-88.4%

Balance sheet

See full
Cash & equivalents$145.3M+205%
Total debt$1.5M-97.6%
Total equity$217.7M+85.7%
Total assets$302.7M+18.1%

Cash flow

See full
Operating cash flow$17.0M+573%
CapEx$217.0K+1.9%
Free cash flow$16.8M+541%

Valuation

See full
Market cap$705.48M+12.4%
Enterprise value$561.65M-12.6%
P/E12.1×-225×
P/S5.2×-4.9×

Profitability

See full
Gross margin95.5%+23.5pp
Operating margin-103.9%-43.0pp
Net margin42.8%+38.6pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity34.8%+31.3pp
Debt / equity-0.5×
Current ratio5.2×-2.7×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfIntangibleAssets.

The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001434647-26-000068

FAQ

What is Zevra Therapeutics, Inc.'s gain loss on disposition of intangible assets?
Zevra Therapeutics, Inc. (ZVRA) reported gain loss on disposition of intangible assets of $0 in Q2 2026.
How has Zevra Therapeutics, Inc.'s gain loss on disposition of intangible assets changed year-over-year?
Zevra Therapeutics, Inc.'s gain loss on disposition of intangible assets decreased by 100.0% year-over-year, from $148.33M to $0.
What does gain loss on disposition of intangible assets mean?
Gain Loss On Disposition Of Intangible Assets as reported by Zevra Therapeutics, Inc. Common Stock.

Ask your AI about Zevra Therapeutics, Inc.'s gain loss on disposition of intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude